Industry Dynamics: Global Nuclear Medicine Market Trends, Current and Future Players, 2026

Market Benefits
The Global Nuclear Medicine is accounted for $3.50 billion in 2017 and is expected to reach $6.50 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Factors such as growing demand for early & precise diagnostic methods, increasing incidence of cancer and cardiovascular disorders and huge demand for single photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging are driving the market growth. However, supply deficiency, reimbursement hurdles for the manufacturer and high capital investment are restricting the growth of the growth. Moreover, rising economies, upcoming radioisotopes and increasing usage across neurological applications are providing ample opportunities for the market growth.
Request Sample PDF with Current Industry Insight @ https://www.amigomarketreports.com/sample-request/5532
Nuclear medicines are used for both diagnostic and therapeutic uses and there are more than 30 specific radiopharmaceuticals used by medical practitioners. Nuclear medicine comes under the field of molecular imaging, which occupy the use of very little amount of radioactive material to detect and treat disease Several forms of nuclear medicines are required in treating cancer, neurological disorders, gastrointestinal and other diseases.
Key Players:
Some of the key players in the Nuclear Medicine Market include Bayer AG, Medtronic, plc, General Electric Co., Cardinal Health, Inc., IBA Group, BWX Technologies, Australian Nuclear Science & Technology Organization (ANSTO), Mallinckrodt plc., Eckert & Ziegler Group, Lantheus Medical Imaging, Inc., Jubilant Life Sciences, Eczacibasi-Monrol Nuclear Products, Curium, Bracco Imaging S.p.A and NTP Radioisotopes SOC Ltd.
Ask Discount @ https://www.amigomarketreports.com/discount-request/5532
Market Segments:
On the basis of application, therapeutic segment witnessed steady growth due to the introduction of advanced protective measures and growing awareness regarding the therapeutic procedures. By geography, North America is dominating the market during the forecasting period owing to increasing aging population, technological advancements and the presence of favorable reimbursement policies in this region.
Products Covered:
• Therapeutic
• Diagnostic
Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa
Access this Report @ https://www.amigomarketreports.com/home/report_details/5532
About Us
We offer the exclusive market research solution for all the industries by performing the comprehensive investigation of industry trends, globally. The Association in every industry such as Technology, Healthcare, Aerospace, Consumable Goods and others demands a market-based solutions for various vital decisions based on productivity.
Our main goal is to Boost and Associate organizations to Build everlasting strategic enhancement and recognize growth Purpose. The organization assists its clients to accomplish business policies and achieve Continuous growth in their respective market domain.
Contact Us
Amigo Market Reports
USA Office
1507 Nolan St,
San Antonio, TX,78202
United States
Toll Free +1 (707) 925 3360
Email : [email protected]